SCHEMBL21875145

SCHEMBL21875145

Cc1ccc(CNC(=O)c2ccn(S(=O)(=O)c3ccccc3)c2)nc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PKM P14618 1/20 0.52
▸ KLKB1 P03952 5/20 0.52
▸ NAMPT P43490 6/20 0.51
▸ GRM4 Q14833 2/20 0.48
▸ KMT2A Q03164 1/20 0.44
▸ RORC P51449 1/20 0.44
▸ HDAC6 Q9UBN7 1/20 0.43
▸ P2RX3 P56373 1/20 0.43
▸ P2RX2 Q9UBL9 1/20 0.43
▸ TUBB4A P04350 1/20 0.43
▸ TUBB P07437 1/20 0.43
▸ TUBA3C P0DPH7 1/20 0.43
▸ TUBA1B P68363 1/20 0.43
▸ TUBA4A P68366 1/20 0.43
▸ TUBB4B P68371 1/20 0.43
▸ TUBB3 Q13509 1/20 0.43
▸ TUBB2A Q13885 1/20 0.43
▸ TUBB8 Q3ZCM7 1/20 0.43
▸ TUBA3E Q6PEY2 1/20 0.43
▸ TUBA1A Q71U36 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21875153 0.93 GRM4 (0.50) KLKB1NAMPTGRM4KMT2ARORC
SCHEMBL21875152 0.88 KLKB1 (0.60) PKMKLKB1NAMPTGRM4KMT2A
SCHEMBL21875140 0.87 RAB9A (0.44) KLKB1NAMPTGRM4KMT2ARORC
SCHEMBL21875108 0.87 PKM (0.52) PKMKLKB1NAMPTHDAC6P2RX3
SCHEMBL21875089 0.85 NAMPT (0.47) PKMKLKB1NAMPTGRM4KMT2A
SCHEMBL21875143 0.85 KMT2A (0.62) KLKB1GRM4KMT2A
SCHEMBL21875082 0.83 KLKB1 (0.58) PKMKLKB1NAMPTGRM4KMT2A
SCHEMBL21875069 0.83 NAMPT (0.48) KLKB1NAMPTGRM4P2RX3P2RX2
SCHEMBL21875106 0.81 KLKB1 (0.49) PKMKLKB1NAMPTGRM4KMT2A
SCHEMBL21875090 0.80 PKM (0.54) PKMKLKB1NAMPTKMT2AHDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113056461-A Arylsulfonyl pyrrole carboxamide derivatives as Kv3 potassium channel activators H.隆德贝克有限公司 2021-06-29 — — CN claimed
US-20200131156-A1 ARYLSULFONYLPYROLECARBOXAMIDE DERIVATIVES AS Kv3 POTASSIUM CHANNEL ACTIVATORS H. LUNDBECK A/S (DK) 2020-04-30 — — US claimed
CN-113056461-A Arylsulfonyl pyrrole carboxamide derivatives as Kv3 potassium channel activators H.隆德贝克有限公司 2021-06-29 — — CN disclosed
US-20200131156-A1 ARYLSULFONYLPYROLECARBOXAMIDE DERIVATIVES AS Kv3 POTASSIUM CHANNEL ACTIVATORS H. LUNDBECK A/S (DK) 2020-04-30 — — US disclosed
US-20200131156-A1 ARYLSULFONYLPYROLECARBOXAMIDE DERIVATIVES AS Kv3 POTASSIUM CHANNEL ACTIVATORS H. LUNDBECK A/S (DK) 2020-04-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200131156-A1 ARYLSULFONYLPYROLECARBOXAMIDE DERIVATIVES AS Kv3 POTASSIUM CHANNEL ACTIVATORS KCNA3, KCNN3, KCNK3 PKM 394/4885KLKB1 784/4885NAMPT 3382/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback